Authors

• Christopher John Lindsell (ORCID: https://orcid.org/0000-0002-3297-2811)
• Anne M. Lachiewicz (ORCID: https://orcid.org/0000-0001-5229-6438)
• Tatyana Der (ORCID: https://orcid.org/0009-0000-3640-5905)
• Adriana M. Rauseo (ORCID: https://orcid.org/0000-0001-9555-2550)
• Martín Maillo (ORCID: https://orcid.org/0009-0009-5967-0723)
• William G. Powderly (ORCID: https://orcid.org/0000-0001-7808-3086)
• Akram Khan (ORCID: https://orcid.org/0000-0003-3091-632X)
• Hussein R. Al‐Khalidi (ORCID: https://orcid.org/0000-0003-1375-0487)
• Derek D. Cyr (ORCID: https://orcid.org/0000-0001-6545-9240)
• Vivek Iyer (ORCID: https://orcid.org/0000-0001-6441-9319)
• Reynold A. Panettieri (ORCID: https://orcid.org/0000-0003-0834-4636)
• Andreas Schmid (ORCID: https://orcid.org/0000-0003-4054-1971)
• Sugeet Jagpal
• Miloni Shah
• Samuel A. Bozzette

Institutions

• Rutgers, The State University of New Jersey (US)
• University of North Carolina at Chapel Hill (US)
• Mayo Clinic (US)
• Oregon Health & Science University (US)
• Duke University (US)
• Washington University in St. Louis (US)
• Johnson University (US)
• Centro Científico Tecnológico - Santa Fe (AR)
• Clinical Research Institute (US)
• University of Kansas Medical Center (US)
• National Center for Advancing Translational Sciences (US)

Publication Details

Journal

CHEST Critical Care

Published

2024-08-23

DOI

https://doi.org/10.1016/j.chstcc.2024.100095

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• U.S. Department of Health and Human Services
• Doris Duke Charitable Foundation
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• Gilead Sciences
• Vanderbilt University
• Cidara Therapeutics
• Vanderbilt University Medical Center
• Cytokinetics
• Shionogi
• National Institutes of Health
• Biomedical Advanced Research and Development Authority
• National Center for Advancing Translational Sciences
• Duke Clinical Research Institute